Daohong Chen

1.1k total citations
29 papers, 856 citations indexed

About

Daohong Chen is a scholar working on Immunology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Daohong Chen has authored 29 papers receiving a total of 856 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 6 papers in Pulmonary and Respiratory Medicine and 6 papers in Oncology. Recurrent topics in Daohong Chen's work include Immune Cell Function and Interaction (5 papers), Immunotherapy and Immune Responses (5 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (4 papers). Daohong Chen is often cited by papers focused on Immune Cell Function and Interaction (5 papers), Immunotherapy and Immune Responses (5 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (4 papers). Daohong Chen collaborates with scholars based in China, United States and Japan. Daohong Chen's co-authors include Takashi Nagaishi, Richard S. Blumberg, Min Li, Xiao-Ming Yin, Atsushi Nakajima, Hideki Iijima, Sunil Badve, Poornima Bhat‐Nakshatri, Harikrishna Nakshatri and Chirayu Goswami and has published in prestigious journals such as Journal of Biological Chemistry, Nature Medicine and The Journal of Experimental Medicine.

In The Last Decade

Daohong Chen

27 papers receiving 844 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daohong Chen China 14 269 264 191 184 100 29 856
Jacqueline M. Tarrant United States 16 304 1.1× 238 0.9× 267 1.4× 124 0.7× 57 0.6× 35 1.0k
Laure Delavallée France 14 357 1.3× 348 1.3× 87 0.5× 121 0.7× 107 1.1× 19 798
Jiandong Zhang China 14 356 1.3× 295 1.1× 81 0.4× 283 1.5× 113 1.1× 36 988
Chantal Degraef Belgium 15 402 1.5× 146 0.6× 254 1.3× 240 1.3× 58 0.6× 22 1.1k
Neelakshi R. Jog United States 15 351 1.3× 375 1.4× 106 0.6× 167 0.9× 33 0.3× 22 931
Jerzy Grabarek Poland 19 492 1.8× 142 0.5× 101 0.5× 172 0.9× 42 0.4× 28 863
Mi Jeong Kim South Korea 15 276 1.0× 159 0.6× 152 0.8× 69 0.4× 55 0.6× 25 759
Deok-Hoon Kong South Korea 10 337 1.3× 221 0.8× 55 0.3× 126 0.7× 65 0.7× 19 830
Kenji Kawai Japan 19 515 1.9× 145 0.5× 66 0.3× 244 1.3× 62 0.6× 93 1.1k

Countries citing papers authored by Daohong Chen

Since Specialization
Citations

This map shows the geographic impact of Daohong Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daohong Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daohong Chen more than expected).

Fields of papers citing papers by Daohong Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daohong Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daohong Chen. The network helps show where Daohong Chen may publish in the future.

Co-authorship network of co-authors of Daohong Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Daohong Chen. A scholar is included among the top collaborators of Daohong Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daohong Chen. Daohong Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Zeng, Qian, Ying Chen, Daohong Chen, et al.. (2024). Efficacy and Safety of Acupuncture in Managing COPD: An Overview of Systematic Reviews. International Journal of COPD. Volume 19. 1721–1739. 2 indexed citations
3.
Chen, Daohong, Jing Yuan, Ying Chen, et al.. (2023). Traditional Chinese medicine in treating ischemic stroke by modulating mitochondria: A comprehensive overview of experimental studies. Frontiers in Pharmacology. 14. 1138128–1138128. 10 indexed citations
4.
Qi, Wenchuan, Lu Liu, Daohong Chen, et al.. (2023). Contribution of cuproptosis and Cu metabolism‐associated genes to chronic obstructive pulmonary disease. Journal of Cellular and Molecular Medicine. 27(24). 4034–4044. 15 indexed citations
5.
Chen, Daohong. (2023). Untoward immune effects of modern medication. Journal of Biomedical Research. 38(1). 17–17. 1 indexed citations
6.
Chen, Daohong, et al.. (2023). Global Research Trends on the Link Between the Microbiome and COPD: A Bibliometric Analysis. International Journal of COPD. Volume 18. 765–783. 5 indexed citations
7.
Chen, Daohong. (2022). Real-world studies: bridging the gap between trial-assessed efficacy and routine care. Journal of Biomedical Research. 36(3). 147–147. 15 indexed citations
8.
Chen, Daohong. (2021). Heparin beyond anti-coagulation. Current Research in Translational Medicine. 69(4). 103300–103300. 21 indexed citations
9.
Chen, Daohong, et al.. (2020). Innovative highlights of clinical drug trial design. Translational research. 224. 71–77. 12 indexed citations
10.
Chen, Daohong. (2018). Dual Targeting Autoimmunity and Cancer: From Biology to Medicine. The Journal of Clinical Pharmacology. 58(8). 990–996. 5 indexed citations
11.
Chen, Daohong & Xiaoshi Zhang. (2017). Cellular immunity augmentation in mainstream oncologic therapy. Cancer Biology and Medicine. 14(2). 121–121. 9 indexed citations
12.
Chen, Daohong, Poornima Bhat‐Nakshatri, Chirayu Goswami, Sunil Badve, & Harikrishna Nakshatri. (2013). ANTXR1, a Stem Cell-Enriched Functional Biomarker, Connects Collagen Signaling to Cancer Stem-like Cells and Metastasis in Breast Cancer. Cancer Research. 73(18). 5821–5833. 92 indexed citations
13.
Li, Min, Bilon Khambu, Hao Zhang, et al.. (2013). Suppression of Lysosome Function Induces Autophagy via a Feedback Down-regulation of MTOR Complex 1 (MTORC1) Activity. Journal of Biological Chemistry. 288(50). 35769–35780. 153 indexed citations
14.
Chen, Daohong, Xi Chen, Min Li, et al.. (2013). CCCP-Induced LC3 lipidation depends on Atg9 whereas FIP200/Atg13 and Beclin 1/Atg14 are dispensable. Biochemical and Biophysical Research Communications. 432(2). 226–230. 23 indexed citations
15.
Nagaishi, Takashi, Hideki Iijima, Atsushi Nakajima, Daohong Chen, & Richard S. Blumberg. (2006). Role of CEACAM1 as a Regulator of T Cells. Annals of the New York Academy of Sciences. 1072(1). 155–175. 38 indexed citations
16.
Chen, Daohong, Hideki Iijima, Takashi Nagaishi, et al.. (2004). Carcinoembryonic Antigen-Related Cellular Adhesion Molecule 1 Isoforms Alternatively Inhibit and Costimulate Human T Cell Function. The Journal of Immunology. 172(6). 3535–3543. 78 indexed citations
17.
Brozović, Suzana, Takashi Nagaishi, Masaru Yoshida, et al.. (2004). CD1d function is regulated by microsomal triglyceride transfer protein. Nature Medicine. 10(5). 535–539. 139 indexed citations
18.
Chen, Daohong & Donald H. Rubin. (2001). Mucosal T Cell Response to Reovirus. Immunologic Research. 23(2-3). 229–234. 7 indexed citations
19.
Mora, Ana L., Daohong Chen, Mark Boothby, & Donald H. Rubin. (1999). Lineage-specific differences among CD8+ T cells in their dependence of NF-κB/Rel signaling. European Journal of Immunology. 29(9). 2968–2980. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026